Aug 29 (Reuters) - Prometic Life Sciences Inc PLI.TO
* Prometic receives Rare Pediatric Disease Designation from U.S. FDA for its plasminogen replacement therapy
* Prometic life sciences - U.S. FDA granted Rare Pediatric Disease Designation to Prometic's Ryplazimä, a plasminogen replacement therapy